EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSBMUG00000017217
Gene Symbol: PSMD14
3 Cross references
213 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 3

Ensembl ID : ENSBMUG00000003142
Gene Symbol: PSMD3
3 Cross references
94 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 7

Ensembl ID : ENSBMUG00000001155
Gene Symbol: PSMD7
3 Cross references
243 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSBMUG00000001055
Gene Symbol: PSMD8
3 Cross references
209 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSBMUG00000018210
Gene Symbol: PSMB11
3 Cross references
228 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSBMUG00000018509
Gene Symbol: PRMT5
3 Cross references
199 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSBMUG00000025718
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSBMUG00000020427
Gene Symbol: PRKCB
3 Cross references
299 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSBMUG00000000305
Gene Symbol: PRKCD
3 Cross references
283 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSBMUG00000025264
Gene Symbol: PRKCH
3 Cross references
241 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSBMUG00000024842
Gene Symbol: PRKCG
3 Cross references
200 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSBMUG00000000402
Gene Symbol: PRKCI
3 Cross references
226 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).